Systematic Review and Meta-Analysis of Adjuvant I131 Lipiodol after Excision of Hepatocellular Carcinoma

Adjuvant Hepatic Intra-arterial Iodine-131-Lipiodol Following Curative Resection of Hepatocellular Carcinoma: A Prospective Randomized Trial

(2013) A. Y. F. Chung et al.   WORLD JOURNAL OF SURGERY

The Global Epidemiology of Hepatocellular Carcinoma: Present and Future

(2011) Katherine A. McGlynn et al.   Clinics in Liver Disease

Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma

(2010) Terence C. Chua et al.   CANCER

Current Approach to Hepatocellular Carcinoma

(2010) Peter Abrams et al.   SURGICAL CLINICS OF NORTH AMERICA

Adjuvant Intra-arterial Iodine-131-labeled Lipiodol for Resectable Hepatocellular Carcinoma

(2009) Wan Yee Lau et al.   ANNALS OF SURGERY

Adjuvant Intraarterial Injection of 131I-Labeled Lipiodol After Resection of Hepatocellular Carcinoma: Progress Report of a Case-Control Study with a 5-Year Minimal Follow-up

(2008) E. Boucher et al.   JOURNAL OF NUCLEAR MEDICINE

Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma

(2008) K.M. Ng et al.   HPB